Psychiatry and Neurology, Neurology · Toledo, OH
NPI
1922094960
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2130 W Central Ave Ste 102103
Toledo, OH, 43606
Phone (419) 291-3900
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
2,943 services
Medicare patients, 2024
299
Average age 68
Drug cost, 2024
$1.8M
4,274 prescriptions
Company payments, 2025
$97.61
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Imran I Ali was code 95816 (neurologic), 99 times for 98 patients. In total Imran I Ali billed 2,943 services in 27 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95816 Neurologic | Facility | 99 | 98 | $40.09 | $3,969 |
| 99214 Office E&M - Established | Office | 74 | 63 | $68.04 | $5,035 |
| 95720 Neurologic | Facility | 68 | 39 | $160.29 | $11K |
| 99213 Office E&M - Established | Office | 39 | 37 | $48.69 | $1,899 |
| 95718 Neurologic | Facility | 32 | 28 | $102.10 | $3,267 |
| 95819 Neurologic | Facility | 29 | 29 | $38.34 | $1,112 |
| 95822 Neurologic | Facility | 27 | 27 | $39.47 | $1,066 |
| 95970 Electrical Nerve Conductivity | Office | 13 | 11 | $8.26 | $107 |
By year: 2022 $162K for 3,871 services; 2023 $178K for 4,095 services; 2024 $38K for 2,943 services.
Medicare prescription drug claims, 2024
In 2024, the drug Imran I Ali prescribed most often to Medicare patients was Lamotrigine, with 621 prescriptions and refills. In total Imran I Ali wrote 4,274 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 621 | 1,021 | 106 | $8,898 |
| Levetiracetam Generic | 517 | 845 | 99 | $26K |
| Lacosamide Generic | 485 | 567 | 59 | $67K |
| Clobazam Generic | 317 | 333 | 37 | $63K |
| Topiramate Generic | 218 | 308 | 34 | $3,599 |
| Xcopri Cenobamate | 177 | 193 | 16 | $265K |
| Carbamazepine Er Carbamazepine | 130 | 199 | 19 | $15K |
| Divalproex Sodium Generic | 103 | 127 | 13 | $6,978 |
| Oxcarbazepine Generic | 102 | 126 | 12 | $14K |
| Lamictal Lamotrigine | 100 | 136 | 14 | $181K |
| Gabapentin Generic | 85 | 127 | 15 | $3,879 |
| Phenytoin Sodium Extended Generic | 85 | 147 | 14 | $3,199 |
| Divalproex Sodium Er Divalproex Sodium | 84 | 119 | 14 | $6,001 |
| Phenobarbital Generic | 81 | 87 | Under 11 | $2,488 |
| Epidiolex Cannabidiol (Cbd) | 79 | 85 | Under 11 | $376K |
Brand drugs: 735 claims; generic drugs: 3,458 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Imran I Ali $97.61 ($97.61 in general payments such as food, travel and fees) from 5 companies. The largest payer was Pfizer Inc. with $63.19.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.